Loading...

Home
ETF
EXEL

EXEL

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

EXEL News

CABOMETYX Shows Significant Efficacy in Advanced NET Treatment

9h agoNewsfilter

U.S.-Iran Interim Deal Boosts Stock Market to New Highs

1d agoYahoo Finance

Exelixis to Present New Therapies at ASCO Meeting

May 21 2026Newsfilter

Exelixis Poised for Doubling Growth Over Next Five Years

May 16 2026Fool

Exelixis Shows Significant Future Growth Potential

May 16 2026Yahoo Finance

Exelixis Q1 2026 Earnings Call Insights

May 06 2026seekingalpha

Exelixis (EXEL) Q1 2026 Earnings Transcript

May 05 2026NASDAQ.COM

Three Biotech Companies Worth Watching

Apr 16 2026NASDAQ.COM

Three Biotech Stocks Worth Watching

Apr 16 2026Fool

Exelixis Market Trends Analysis

Apr 01 2026Fool

Exelixis Investment Insights from Motley Fool

Apr 01 2026NASDAQ.COM

High-Quality Healthcare Stocks Under $50

Mar 18 2026Fool

Amazon Launches Ultra-Fast Delivery Service

Mar 17 2026Fool

Exelixis Aims to Expand Beyond Cabozantinib Franchise

Feb 28 2026NASDAQ.COM

Exelixis Aims to Become a Top Oncology Player with Expanding Pipeline

Feb 28 2026Fool

Global Oncology Market Expected to Reach $748.17 Billion

Feb 24 2026PRnewswire